
pmid: 10961429
We demonstrated that nerve growth factor (NGF) levels were increased in hippocampus and cortical areas, as well as in cerebrospinal fluid (CSF) of patients with Alzheimer's disease (AD). Such increases may, at least in part, be due to a decreased expression of the NGF high affinity receptor trkA. Measurement of CSF levels of NGF may add to the repertoire of potential biochemical diagnostic markers in living AD patients.
Cerebral Cortex, Alzheimer Disease, Parietal Lobe, Humans, Nerve Growth Factors, Receptors, Nerve Growth Factor, Receptor, trkA, Hippocampus
Cerebral Cortex, Alzheimer Disease, Parietal Lobe, Humans, Nerve Growth Factors, Receptors, Nerve Growth Factor, Receptor, trkA, Hippocampus
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 23 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
